Clinical Trial

Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 16, 2026 (before its estimated May 6, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, randomized, open-label, Phase II clinical study to evaluate the efficacy, safety, and pharmacokinetics of LP-005 injection in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-30.
Status change: Recruiting → Active, Not Recruiting 2026-01-14
Trial Details
NCT Number NCT07212426
Lead Sponsor Longbio Pharma
Conditions PNH - Paroxysmal Nocturnal Hemoglobinuria
Enrollment 30 participants
Start Date 2024-11-14
Primary Completion 2026-05-06 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-16